Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • SDPA_Pet
    Senior Member
    • Apr 2013
    • 222

    #16
    Originally posted by Markiyan View Post
    Clustering means bridge amplification for pre ExAmp (non-patterned flowcells) - in situ PCR on the flow cell surface oligos lawn. Has similar rukes/laws to a regular PCR, only the product stays in situ, forming a forest from DNA strands.

    For ExAmp Chemistry (patterned flowcells) - Clustering means cluster formation using Isothermal Amplification.
    (In theory only on the occupied nanowell, in practice, especially at low loading concentrations a few neighbours may join in too...).

    Have a read about ExAmp & Hiseq4000:
    http://core-genomics.blogspot.co.uk/...d-to-know.html
    Thank you. I did my sequencing on old platform HiSeq 2500.

    Comment

    • fanli
      Senior Member
      • Jul 2014
      • 197

      #17
      Out of curiosity, why are you joining the read pairs? A lot of the metagenomics software out there now supports paired end reads as input. The metaSPAdes assembler @GenoMax mentioned requires paired end data IIRC.

      Comment

      • SDPA_Pet
        Senior Member
        • Apr 2013
        • 222

        #18
        Originally posted by fanli View Post
        Out of curiosity, why are you joining the read pairs? A lot of the metagenomics software out there now supports paired end reads as input. The metaSPAdes assembler @GenoMax mentioned requires paired end data IIRC.
        Hey, I did try metaSPAdes, less than 1% of total reads assembled. A lot of people tried alternative methods, joined paired-ends and get long reads, but don't assembled reads. Then, use the long merged reads to do BLAST or other annotations.

        Comment

        • fanli
          Senior Member
          • Jul 2014
          • 197

          #19
          Would something like kraken or CLARK not be helpful? Are you trying to assemble and annotate de novo genomes? Or trying to figure out the microbial composition and functional content? I guess my point is you would discard ~40% of your data in the joining process, which may not be necessary depending on your task of interest.

          Comment

          • SDPA_Pet
            Senior Member
            • Apr 2013
            • 222

            #20
            Originally posted by fanli View Post
            Would something like kraken or CLARK not be helpful? Are you trying to assemble and annotate de novo genomes? Or trying to figure out the microbial composition and functional content? I guess my point is you would discard ~40% of your data in the joining process, which may not be necessary depending on your task of interest.
            I am not interested in a specific genome in the soil community. Basically, I am just interested in the microbial composition and functional content. There is another way that people usually do. They don't assemble or merge pairs and they just blast using raw data. However, I think blast using ~150bp reads is worse. Some publication shows the intermediate length (merged pair) is better than assembled longer reads or unasembled short reads for the question that I am asking for.

            Comment

            • fanli
              Senior Member
              • Jul 2014
              • 197

              #21
              You might find this benchmark to be helpful:


              My understanding is that you are better off using newer k-mer based approaches as opposed to BLAST. I've had reasonable success with kraken, although the memory requirements are somewhat onerous. You also have to be extremely careful about removing contaminant (aka human) sequences as these tend to get misclassified.

              Another option is kallisto (https://github.com/pachterlab/metakallisto) but I have yet to be able to even build a database due to memory constraints.

              Comment

              • SDPA_Pet
                Senior Member
                • Apr 2013
                • 222

                #22
                Originally posted by fanli View Post
                You might find this benchmark to be helpful:


                My understanding is that you are better off using newer k-mer based approaches as opposed to BLAST. I've had reasonable success with kraken, although the memory requirements are somewhat onerous. You also have to be extremely careful about removing contaminant (aka human) sequences as these tend to get misclassified.

                Another option is kallisto (https://github.com/pachterlab/metakallisto) but I have yet to be able to even build a database due to memory constraints.
                I will try. Can you gimme the Kraken link? Thanks.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 11:41 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                21 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                35 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                44 views
                0 reactions
                Last Post SEQadmin2  
                Working...